Baker Mayfield has thrown just one interception in seven games since Odell Beckham Jr. went down and the Browns quarterback has a friendly matchup against the Jets in week 16.
Baker Mayfield has thrown just one interception in seven games since Odell Beckham Jr. went down and the Browns quarterback has a friendly matchup against the Jets in week 16.
New Delhi [India], January 23 (ANI): Congress leader Rahul Gandhi on Saturday will begin his three-day visit to Tamil Nadu, which is slated to go to polls later this year.
Mathews came in to bat at 7-2 after James Anderson had dismissed both Kusal Perera (6) and Oshada Fernando (0) in the morning session.
SAN ANTONIO — Luka Doncic had 36 points, 11 assists and nine rebounds and the Dallas Mavericks withstood a late rally to beat the San Antonio Spurs 122-117 on Friday night. San Antonio lost starting point guard Dejounte Murray in the opening minute. The severity of the injury is unknown. DeMar DeRozan had 29 points, LaMarcus Aldridge added 26s, and Keldon Johnson had 17 points and 14 rebounds for the Spurs. Dallas won its second straight after a three-game losing streak. San Antonio is 2-5 at home. After trailing by as many as 18 points, the Spurs pulled to 113-107 with four minutes remaining on a turnaround left-handed hook by Aldridge. Two minutes later, DeRozan cut the advantage to 113-111 with a pair of free throws. DeRozan made one of two free throws to pull the Spurs within 113-112, but Doncic made an 11-footer and then assisted on Jalen Brunson’s 3-pointer. Kristaps Porzingis and Tim Hardaway Jr. had 21 points each for the Mavericks. Murray’s absence had a big impact on San Antonio’s perimeter defence in the first half. The Mavericks were 14 for 39 on 3-pointers, including 10 for 21 in the first half. Dallas entered the game averaging 12.6 3-pointers on 37.6 attempts. TIP-INS Mavericks: Doncic fell a rebound shy of his sixth triple-double of the season. In just his third season with the Mavericks, Doncic is the franchise leader in triple-doubles with 30. … Dorian Finney-Smith, Maxi Kleber, Dwight Powell and Josh Richardson were because of health and safety protocols. Spurs: Starting guard Derrick White missed his 11th straight game after fracturing his left second toe. … The Spurs trailed by 15-plus points for the fifth time this season. They have lost each of those games. ... San Antonio made seven 3-pointers in the first quarter tonight, which is one shy of its franchise record for a single quarter. … Tre Jones entered the game in the first quarter for his earliest action in his rookie season. Jones, who is averaging 2.8 points in 3.6 minutes through five games, did not return after playing two minutes. UP NEXT Mavericks: Host Houston on Saturday night. Spurs: Host Washington on Sunday. Raul Dominguez, The Associated Press
"Jeopardy!" promised "something crazy" would happen during Friday's "Final Jeopardy!" And the game show didn't disappoint.
Donald Trump is responsible for the Jan. 6 riot, but so are you, according to the House Republican leader.
Trae Young scored a season-high 43 points, Clint Capela had 13 points, 19 rebounds and 10 blocks, and the Atlanta Hawks topped the Minnesota Timberwolves 116-98 on Friday night. Young scored 25 points in the first half as the Hawks took a 19-point lead at halftime. ''I'm never going to be surprised when Trae's scoring 40 or 30 or 12 assists or whatever the number is,'' Hawks coach Lloyd Pierce said.
Indore (Madhya Pradesh) [India], January 23 (ANI): A Central Bureau of Investigation (CBI) court in Indore on Friday sentenced a doctor to five years of imprisonment and Rs 1,000 fine in a fraud case.
New Delhi [India], January 23 (ANI): Sixteen trains scheduled to New Delhi on Saturday, including Howrah-New Delhi Special and Saharsa-New Delhi Special, are running late due low visibility conditions and other operational reasons, said Chief Public Relations Officer (CPRO), Northern Railway.
The Mega Millions jackpot has increased to $1 billion for Friday night's drawing. The winning numbers are 4-26-42-50-60 with a Mega Ball number of 24. If a lucky lottery player wins, this will mark the second-largest jackpot in Mega Millions history and the third-largest in U.S. lottery history, Mega Millions lottery officials said.
The Raptors exacted their revenge with a gritty blowout win over the Miami Heat in the second of a double-header.
Together, they’ve amassed over 50,000 five-star ratings
House Minority Leader joins 'Hannity' with reaction to the controversial decision
Positive results from COLCORONA trial show that colchicine is the only effective oral medication for treating non-hospitalized patientsMONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The analysis of the 4159 patients in whom the diagnosis of COVID-19 was proven by a naso-pharyngeal PCR test has shown that the use of colchicine was associated with statistically significant reductions in the risk of death or hospitalization compared to placebo. In these patients with a proven diagnosis of COVID-19, colchicine reduced hospitalizations by 25%, the need for mechanical ventilation by 50%, and deaths by 44%. This major scientific discovery makes colchicine the world’s first oral drug that could be used to treat non-hospitalized patients with COVID-19. “Our research shows the efficacy of colchicine treatment in preventing the ‘cytokine storm’ phenomenon and reducing the complications associated with COVID-19,” said Dr. Jean-Claude Tardif, Director of the MHI Research Center, Professor of Medicine at the Université de Montréal and Principal Investigator of the COLCORONA trial. “We are pleased to offer the first oral medication in the world whose use could have a significant impact on public health and potentially prevent COVID-19 complications for millions of patients.” Treating patients at risk of complications with colchicine as soon as the diagnosis of COVID-19 is confirmed by PCR reduces their risk of developing a severe form of the disease and, consequently, reduces the number of hospitalizations. Prescribing colchicine to patients could help alleviate the problems of hospital congestion and reduce healthcare costs here and around the world. “Our innovative research program also proves that the Montreal Heart Institute can make rapid scientific breakthroughs in a way that is economically viable for patients by repurposing existing drugs,” continued Dr. Jean-Claude Tardif. COLCORONA is a contact-less, randomized, double-blind, placebo-controlled clinical trial that took place at home. It has been conducted in Canada, the United States, Europe, South America and South Africa. It was designed to determine whether colchicine could reduce the risk of severe complications associated with COVID-19. COLCORONA was conducted among approximately 4,500 COVID-19 patients not hospitalized at the time of enrollment, with at least one risk factor for COVID-19 complications. This is the world’s largest study testing an orally administered drug in non-hospitalized patients with COVID-19. COLCORONA was coordinated by the Montreal Heart Institute’s Montreal Health Innovations Coordinating Center (MHICC), and funded by the Government of Quebec, the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (NIH), Montreal philanthropist Sophie Desmarais, and the COVID-19 Therapeutics Accelerator, an initiative launched by the Bill & Melinda Gates Foundation, Wellcome and Mastercard. CGI, Dacima and Pharmascience of Montreal were also collaborators in the trial. The Montreal Heart Institute and its global partners would like to warmly thank the participants and researchers for their collaboration in the COLCORONA clinical trial. For more information, visit colcorona.net. About the Montreal Heart InstituteFounded in 1954, the Montreal Heart Institute constantly aims for the highest standards of excellence in the cardiovascular field through its leadership in clinical and basic research, ultra-specialized care, professional training, and prevention. It houses the largest research center in Canada, the largest cardiovascular prevention center in the country, and the largest cardiovascular genetics center in Canada. The Institute is affiliated with the Université de Montréal and has more than 2,000 employees, including 245 doctors and more than 85 researchers. icm-mhi.org About the Montreal Health Innovations Coordinating Center (MHICC)The Montreal Health Innovations Coordinating Center (MHICC) is a leading academic clinical research organization and an integral part of the Montreal Heart Institute (MHI). The MHICC possesses an established network of collaborators in over 4,500 clinical sites in more than 35 countries. It has specific expertise in precision medicine, low-cost high-quality clinical trials, and drug repurposing. mhicc.org About PharmascienceFounded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec. With its head office located in Montreal and its 1,500 employees, Pharmascience Inc. is a private pharmaceutical company with deep roots in Canada, and whose global reach spans across more than 60 countries. Ranked 47th among the top 100 Canadian investors in Research and Development (R&D), thanks to $49,5 million investment in 2018, Pharmascience Inc. is one of the largest manufacturer of generic drugs in the country. pharmascience.com About CGIFounded in 1976, CGI is one of the world’s largest information technology (IT) and management consulting firms. From hundreds of locations around the world, CGI offers a complete portfolio of services and solutions: strategic IT and management consulting services, systems integration services, intellectual property solutions as well as IT and business process management services in delegated mode. cgi.com/canada About DacimaFounded in 2006, Dacima Software Inc. is a leading innovator in Electronic Data Capture (EDC) software for clinical research. Dacima’s EDC software, Dacima Clinical Suite, is a fully feature EDC software application with integrated modules for patient randomization (IWRS), supply management, ePRO, eDiary, medical coding and eConsent. Dacima’s flexible and highly configurable EDC platforms allow for the design of all types of study designs including clinical trials, patient registries, observational studies and web surveys through an intuitive user-friendly web interface. dacimasoftware.com About the COVID-19 Therapeutics AcceleratorThe Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard with support from public and philanthropic donors to speed up the response to the COVID-19 pandemic by identifying, assessing, developing, and scaling up treatments. Its partners are committed to equitable access, including making products available and affordable in low-resource settings. https://www.therapeuticsaccelerator.org/ Media Contacts:Camille TurbideCamille.email@example.comCanada : + 514 755-5354Europe : +33 07 85 95 11 29 United StatesChristy Maginnchristymmaginn@msn.com+ 1 703 297-7194
Knowing they'd be without Alex Ovechkin and three other prominent players for their home opener, the Washington Capitals talked about the gaping holes left in the lineup and then rallied around them. Playing without Ovechkin, center Evgeny Kuznetsov, defenseman Dmitry Orlov and goaltender Ilya Samsonov because of pandemic protocols, the Capitals gutted out a 4-3 shootout victory against the Buffalo Sabres on Friday night to snap an early-season losing streak. ''Sometimes when you're faced with adversity, those are the sweetest wins: the ones where you have to overcome some obstacles,'' first-year coach Peter Laviolette said.
CHICAGO — Patrick Kane had a goal and an assist, and the Chicago Blackhawks beat the Detroit Red Wings 4-1 on Friday night for their first win of the season. Andrew Shaw, Calvin de Haan and Mattias Janmark also scored for Chicago in its home opener after beginning the season with a four-game trip. Dylan Strome and Alex DeBrincat each had two assists. Kevin Lankinen, a 25-year-old rookie signed by Chicago as a free agent in 2018, stopped 30 shots in picking up his first NHL victory in his second straight start. Only Dylan Larkin, crossing the crease and getting Lankinen to commit, beat the Helsinki, Finland, native. The Blackhawks (1-3-1) controlled the first period, withstood the Red Wings’ 12-5 shot advantage in the second, and held off a late surge by Detroit (2-3-0), which squandered five power plays. Kane opened the scoring on a power play in the first period, posting his third goal in four games. He controlled Strome’s pass from left wing and flipped it past Thomas Greiss’ right shoulder before defenceman Alex Biega could check him. Greiss stopped 24 shots. Strome also set up the Blackhawks’ second goal, feeding the puck from behind the goal line through three Red Wings to de Haan for a 50-foot slap shot past Greiss’ left arm 7:58 into the second. Shaw turned Kane’s pass into the slot into the third Chicago goal on a power play 6:17 into the third.Larkin raced in on right wing 12:22 into the third, sped by Lankinen, and flipped the puck over the goalie for Detroit’s only goal. Mattias Janmark added a late open-net goal for Chicago while the Blackhawks were shorthanded. TURNAROUND Lankinen, signed by Chicago as a free agent in 2018, allowed five goals in his first NHL start, Tuesday’s 5-4 overtime loss at Florida. The Blackhawks had allowed five goals in each of their first four games, with Malcolm Subban in net for the opener at Tampa Bay and Collin Delia playing next two games. EMPTY FEELING The usual enthusiastic roar of the Chicago crowd behind national anthem singer Jim Cornelison was missing on Friday night, replaced by an empty building and recorded fan noise. Cornelison himself was on tape rather than live. Instead of the usual 20,000-plus, there were no more than 80 onlookers, including reporters, television personnel, game operations personnel, Chicago and Detroit executives, and scouts from other teams in United Center. WHAT’S NEXT The Blackhawks and Red Wings play again on Sunday morning in Chicago, the second of eight meetings this season. ___ More AP NHL coverage: https://apnews.com/hub/NHL and https://twitter.com/AP_Sports The Associated Press
According to reports by the Wall Street Journal and Bloomberg, NBC Sports Group Chairman Pete Bevacqua told staffers in a memo that the NBC Sports Network cable channel is shutting down the end of this year. While it’s unclear what will happen to some of the content it currently airs, stuff like NHL games and NASCAR races will shift to the USA Network channel instead, and they plan to dual-broadcast some of those prior to the channel going dark. This could also push some content to NBCUniversal’s streaming platform Peacock, but the focus right away seems to be strengthening USA Network as an option against channels like Warner’s TNT/TBS.
LA’UPULEHU-KONA, Hawaii (AP) — Jerry Kelly and Darren Clarke shared the second-round lead Friday in the Mitsubishi Electric Championship after first-round leader Retief Goosen stumbled late at Hualalai. Kelly birdied the 18th for a 5-under 67 to match Clarke at 13-under 131 with a round left in the first PGA Tour Champions event of the year. “You strive to be in the last group,” Kelly said.
TULSA, Okla. and VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Jericho Oil Corporation (“Jericho”) (TSX-V: JCO; OTC PINK: JROOF) is pleased to announce that it is has entered into an agreement for the acquisition of all the assets of Hydrogen Technologies Inc. (“HTI”). HTI holds robust intellectual property for a breakthrough high-temperature Dynamic Combustion Chamber (“DCC”) boiler that enables zero-emissions hydrogen to generate heat, hot-water, high-temperature steam, and Combined Heat & Power (“CHP”) through a closed-loop process. The closing of the acquisition remains subject to the approval of the TSX Venture Exchange and also the approval of the shareholders of HTI. HTI’s patented zero emissions DCC boiler system aims to decarbonize the nearly $30 billion global commercial and industrial heating industry while providing best-in-class energy efficiencies. The traditional water heating, steam generation and CHP market has been powered by fossil fuel for over 100 years, producing harmful Carbon Dioxide (CO2), nitrogen oxides (NOx) and sulfur dioxide (SO2) emissions which are increasingly being phased out or eliminated through government-led emission-based performance standards worldwideGlobally, 85% of all Industrial Boilers emit harmful greenhouse gas emissions (GHG) with over 35% of the Industrial Boiler install base still powered by coalCritically, 37% of all fossil fuels utilized in US Industry today are burned to produce steam, with all the major industrial energy users devoting significant proportions of their fossil fuel consumption to steam production: food processing (57%), pulp and paper (81%), chemicals (42%), petroleum refining (23%) and primary metals (10%) Steam is used in 80% of the electrical generation in the US HTI’s DCC can be used for a variety of commercial and industrial applications, generating zero emission electricity when combined with a turbine genset in CHP applications. The patented DCC technology: Awarded the Solar Impulse Efficient Solutions Label in 2019Requires no air permit, with water as the only by-productEliminates all NOx, SOx and CO2 emissions through a closed-loop combustion processProduces at a 30% greater efficiency than traditional fossil fuel boilers with a 97% overall boiler thermal efficiencyCritically, the Total Cost of Production ($ / lb steam) is cost competitive to traditional hydrocarbon boiler systems There are large commercial and industrial (“C&I”) markets which HTI is specifically targeting with their zero emissions DCC Hydrogen Boiler. According to market research, the C&I market for boilers represents a $30 billion annual market and is estimated to grow between 5 to 7% per year, over the next seven years, with low and zero carbon solutions expected to outpace: Commercial markets for heat or hot water as an end-use: Shopping malls, universities and institutions, airports, hotels, stadiums, hospitals, and government buildingsIndustrial markets for steam-generation as an industrial process end-use: refining and petrochemical, pulp and paper, chemical and pharmaceutical, food processing, refrigeration, metals, and mining among othersFor Combined Heat & Power applications: Utility Power Generation, Energy Storage, On-Site Distributed Energy, and Data Centers will be critical markets for a zero-emissions DCC solution As a part of the transaction, Jericho will also be acquiring the highly dedicated and robust technical team from HTI including its founder, Ed Stockton and President, Janet Reiser. Adding Ed’s technical capabilities and expertise related to the hydrogen market will allow for a seamless transition in building up the DCC boiler’s commercial success within our low-carbon energy portfolio. Prior to founding HTI in 2005, Ed spent most of his career with Florida Power & Light (now NextEra Energy) focused on low-carbon technologies with direct power plant experience, including equipment startup, maintenance, due diligence, government relations and regulation promulgation. Janet, with over 35 years of experience in energy management and engineering, most recently running the governmental Alaska Energy Authority, will continue to lead HTI’s day-to-day operations and sales efforts. As consideration for the technology acquisition, Jericho will deliver to HTI, 6,700,000 shares of Jericho Common Stock. The Shares will be restricted pursuant to agreed upon milestones related to commercial deployment and technological successes. Jericho will pay the out-of-pocket costs associated with the transaction on behalf of HTI and winding up their entity. Brian Williamson, CEO of Jericho Oil Corporation, states, “We are excited to announce the acquisition of HTI’s patented and novel zero emission hydrogen technology and welcome their world class team. The world is increasingly demanding a transition away from traditional energy sources to low carbon solutions – HTI’s hydrogen solution expands our portfolio to include a technology that will transition one of the largest carbon emitters to a zero-emission energy source. We look forward to receiving the exchanges final approval and updating our shareholders accordingly on our go-forward energy portfolio strategy.” Separate from the transaction, Jericho also announces that it has granted incentive stock options (the “Options”), pursuant to its stock option plan (the “Plan”), of 700,000 common shares of the Company, to certain directors and officers of the Company. The Options are exercisable at a price of $0.45 CAD for a period of up to 5 years. This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Jericho's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Jericho's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Although Jericho believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Forward-looking information and statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information and statements which include, but are not limited to: the effects of and risks associated with the ongoing COVID-19 pandemic, the impact of general economic conditions, industry conditions and current and future commodity prices including sustained low oil prices, significant and ongoing stock market volatility, currency and interest rates, governmental regulation of the oil and gas industry, including environmental regulation; geological, technical and drilling problems; unanticipated operating events; competition for and/or inability to retain drilling rigs and other services; the availability of capital on acceptable terms; the need to obtain required approvals from regulatory authorities; liabilities inherent in oil and gas exploration, development and production operations; and the other factors described in our public filings available at www.sedar.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive. The forward-looking information and forward-looking statements contained in this news release are made as of the date of this news release, and Jericho does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. CONTACT: Adam Rabiner Director, Investor Relations604.firstname.lastname@example.org
ST. PAUL, Minn. — Zach Parise scored his first goal of the season to break a second-period tie, spurring the Minnesota Wild to a 4-1 victory over the San Jose Sharks on Friday night. Joel Eriksson Ek had an early goal for the Wild against former teammate Devan Dubnyk, who made 25 saves for the Sharks on the Minnesota ice he called home for the previous six years. Kevin Fiala and Jordan Greenway added empty-netters late for the Wild (4-1-0) in their home opener, maintaining momentum from their strong start on the road. Matt Nieto scored for the Sharks (2-3-0) and their travelling show, five games into a season-opening eight-game trip that will likely grow longer given local virus restrictions preventing them from on-ice activity in San Jose. Parise and Fiala, the Wild’s top two goal scorers last season, went the first four games without a point. Parise ended that streak in typical fashion by knocking in from the crease a rebound of Nick Bjugstad’s shot, seconds after Dubnyk had denied his friend with a kick save. There's no better example of the increased confidence on the Wild than Eriksson Ek, who has five points in five games. The 23-year-old centre, thriving on the third line with Jordan Greenway and Marcus Foligno, scored his third goal of the season on a tip-in past Dubnyk just 5:01 into the game. That gave the Wild an opportunity to unveil their new goal song: the 1992 rap anthem “Jump Around” by House of Pain. Wild goalie Cam Talbot let in Nieto's shot through traffic from the slot just 1:11 later. Soon after that, he appeared to suffer a lower-body injury and needed a few minutes to compose himself after medical examination. Talbot stayed in the game but was replaced after the first intermission by Kaapo Kähkönen, who stopped all 17 shots he faced. Kähkönen won his only start at Anaheim on Wednesday. FEELS LIKE HOME Dubnyk's family has remained in Minnesota, with the Sharks unsure when they'll be clear to settle in Northern California. With league permission, his wife and three children were slated to come to the game among the approximately 80 attendees, all family and friends of the Wild. Visiting teams are normally restricted this season from having guests at games. Even without an actual crowd, save for the high school jerseys draped over cardboard cutouts in priciest seats, the Wild played the customary tribute video to Dubnyk during a first-period break. Players from both teams tapped their sticks against the boards in appreciation. SHARK BITES LW Ryan Donato, who was also traded by the Wild to the Sharks during the off-season, had a game-high five shots on goal. ... Karlsson assisted on Nieto's goal and has 21 points in 16 career games against the Wild. INTO THE WILD The Wild went 0 for 3 on the power play and are 1 for 23 this season. ... LW Nico Sturm was scratched with an illness, the team said, unrelated to COVID-19. Brad Hunt, a healthy scratch in the first four games, moved up from the blue line to take his place. UP NEXT The two teams play here again on Sunday night. All eight of their matchups this season are divided into two-game sets. ___ More AP NHL: https://apnews.com/NHL and https://twitter.com/AP_Sports Dave Campbell, The Associated Press
Major League Baseball pays tribute to the legendary Hall of Fame career of Hank Aaron on this edition of FastCast